Select Publications

Journal articles

Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, vol. 99, pp. 103456, http://dx.doi.org/10.1016/j.drugpo.2021.103456

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, vol. 98, pp. 103379, http://dx.doi.org/10.1016/j.drugpo.2021.103379

Camara H; Zhang Y; Lafferty L; Vallely AJ; Guy R; Kelly-Hanku A, 2021, 'Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis', BMC Public Health, vol. 21, pp. 1503, http://dx.doi.org/10.1186/s12889-021-11554-6

Lafferty L; Smith K; Causer L; Andrewartha K; Whiley D; Badman SG; Donovan B; Anderson L; Tangey A; Mak D; Maher L; Shephard M; Guy R; TTANGO2 Collaboration , 2021, 'Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators.', Implement Sci Commun, vol. 2, pp. 127, http://dx.doi.org/10.1186/s43058-021-00232-8

Hill AO; Bavinton BR; Kaneko N; Lafferty L; Lyons A; Gilmour S; Armstrong G, 2021, 'Associations Between Social Capital and HIV Risk-Taking Behaviors Among Men Who Have Sex with Men in Japan', Archives of Sexual Behavior, vol. 50, pp. 3103 - 3113, http://dx.doi.org/10.1007/s10508-021-02097-3

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Treloar C; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, vol. 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, vol. 96, pp. 103469, http://dx.doi.org/10.1016/j.drugpo.2021.103469

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, vol. 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, vol. 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277

Rance J; Lafferty L; Treloar C, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C)', Harm reduction journal, vol. 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4

Bryant J; Horwitz R; Gray RM; Lafferty L; Jops P; Blunden H; Hudson S; Brener L, 2021, 'Improving access to drug and alcohol treatment in NSW Australia: The role of self-determination and peer support', Health and Social Care in the Community, http://dx.doi.org/10.1111/hsc.13639

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, vol. 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106

Camara H; Zhang Y; Lafferty L; Vallely A; Guy R; Kelly-Hanku A, 2020, 'Qualitative evidence synthesis on self-collection for human papillomavirus–based cervical screening: Protocol for systematic review', JMIR Research Protocols, vol. 9, pp. e21093, http://dx.doi.org/10.2196/21093

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, vol. 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, vol. 77, pp. 102693 - 102693, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, vol. 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Settumba SN; Shanahan M; Butler T; Schofield P; Lafferty L; Simpson P; Chambers G, 2019, 'Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders.', Applied Health Economics and Health Policy, http://dx.doi.org/10.1007/s40258-019-00484-5

Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, vol. 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987

Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, vol. 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141

Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, vol. 15, http://dx.doi.org/10.1186/s12954-018-0246-6

hilferty F; Lafferty L; valentine K; Cale J; Zmudski F, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections, vol. 5th edition, pp. 34 - 47, https://icpa.org/library/a-preview-of-the-advancing-corrections-journal-edition-5-2018/

Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, vol. 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030

Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, vol. 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562

Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, vol. 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627

Lafferty L; Treloar C; Butler T; Guthrie J; Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, vol. 4, http://dx.doi.org/10.1186/s40352-016-0040-z

Lafferty L; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, vol. 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040

Lafferty L; Chambers GM; Guthrie J; Butler T, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, vol. 3, pp. 3 - 7, http://dx.doi.org/10.1186/s40352-015-0020-8

Conference Posters

Lafferty LM; Rance J; Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017

Rance JA; Lafferty L; Treloar C, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015

Conference Presentations

Lafferty L; Bryant J; Mao L; Hull P; Gray R; Treloar C, 2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019

Lafferty L; Rance J; Treloar C, 2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019

Rance J; Lafferty L; Treloar C, 2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018

Rance J; Lafferty L; Treloar C, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018

Lafferty LM; Rance J; Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017

Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017

Lafferty LM; Treloar C; Steele M; van Breda N; Hiley S; Salmon A, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016

Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September 2016 - 01 October 2016

Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 September 2016 - 09 September 2016

Lafferty LM; Treloar C; Butler T, 2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 May 2016 - 20 May 2016

Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March 2016 - 01 April 2016

Lafferty LM; Guthrie J; Chambers GM; Butler T, 2015, 'Social capital of men in prison living with hepatitis C', presented at 2nd National Complex Needs Conference, 17 November 2015 - 18 November 2015

Lafferty LM, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013

Lafferty LM; Guthrie J; Chambers GM; Butler T, 2013, 'Determining social capital indicators for accessing treatment and changes in QALYs post-treatment: HCV treatment among inmates in NSW', presented at National Indigenous Health Conference, Cairns, Australia, 25 November 2013 - 27 November 2013

Conference Abstracts

Salmon AM; Silins E; Belackova V; Jauncey M; Day CA; Lafferty L; Wood W, 2018, 'SYMPOSIUM: ABOVE AND BEYOND - AN EXPLORATION OF CARE BEYOND SUPERVISED INJECTIONS AT THE UNITING MEDICALLY SUPERVISED INJECTING CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S14 - S14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lafferty L; Wild C; Rance J; Treloar C, 2017, 'P30 Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia's current policy frameworks', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 22, http://dx.doi.org/10.1016/s2055-6640(20)30771-8

Lafferty L; Rance J; Treloar C, 2017, 'P31 Treatment as prevention in the prison setting: prisoners’ perspectives', in Journal of Virus Eradication, Elsevier BV, Vol. 3, pp. 22 - 23, http://dx.doi.org/10.1016/s2055-6640(20)30772-x


Back to profile page